Bavarian Nordic A/S (BAVA.CO)
BAVA.CO on Copenhagen Stock Exchange
137.25DKK
17 Apr 2019
137.25DKK
17 Apr 2019
Change (% chg)
kr.-1.40 (-1.01%)
kr.-1.40 (-1.01%)
Prev Close
kr.138.65
kr.138.65
Open
kr.138.40
kr.138.40
Day's High
kr.138.95
kr.138.95
Day's Low
kr.137.00
kr.137.00
Volume
81,808
81,808
Avg. Vol
156,083
156,083
52-wk High
kr.214.80
kr.214.80
52-wk Low
kr.117.75
kr.117.75
About
Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate... (more)
Overall
| Beta: | 1.69 |
| Market Cap(Mil.): | kr.4,434.62 |
| Shares Outstanding(Mil.): | 32.31 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| BAVA.CO | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 62.06 | 62.40 |
| EPS (TTM): | -11.28 | -- | -- |
| ROI: | -13.20 | 12.17 | 11.78 |
| ROE: | -15.44 | 13.11 | 12.61 |
Estimates